Clinical Trial

SIII and Spontaneous Regression in Lumbar Disc Herniation

Study acronym: SIII-LDH
Completed
View on ClinicalTrials.gov →
Summary
This study aimed to investigate the role of the Systemic Immune-Inflammatory Index (SIII) in patients with lumbar disc herniation (LDH) and to evaluate its potential clinical relevance in relation to treatment modality.
Trial Details
NCT Number NCT07367503
Lead Sponsor Çanakkale Onsekiz Mart University
Conditions Inflammation, Neutrophil, Lymphocyte, Neurosurgery
Enrollment 130 participants
Start Date 2020-06-01
Primary Completion 2023-01-30 (estimated)
Study Completion 2023-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-26